Socioeconomic disparities in survival after high‐risk neuroblastoma treatment with modern therapy
| Autor: | Lisa Diller, Karina Braga Ribeiro, Kira Bona, Jonathan M. Marron, Anran Li, Daniel J. Zheng, Clement Ma |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Adolescent Population Disease Insurance Coverage Article Cohort Studies Neuroblastoma 03 medical and health sciences 0302 clinical medicine Epidemiology Humans Medicine Healthcare Disparities Child education Poverty Socioeconomic status education.field_of_study Univariate analysis business.industry Hazard ratio Infant Hematology United States Confidence interval Social Class Socioeconomic Factors Oncology Child Preschool 030220 oncology & carcinogenesis Pediatrics Perinatology and Child Health business 030215 immunology Demography Cohort study |
| Zdroj: | Pediatr Blood Cancer |
| ISSN: | 1545-5017 1545-5009 1991-1998 |
| DOI: | 10.1002/pbc.29127 |
| Popis: | BACKGROUND Modern therapeutic advances in high-risk neuroblastoma have improved overall survival (OS), but it is unclear whether these survival gains have been equitable. This study examined the relationship between socioeconomic status (SES) and overall survival (OS) in children with high-risk neuroblastoma and whether SES-associated disparities have changed over time. PROCEDURE In this population-based cohort study, children |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text